Conference Coverage
News
Expert: Eliminating HCV ‘sounds ambitious, but I think it’s possible’
An estimated one in three inmates in the United States has chronic HCV.
Conference Coverage
HCV treatment with DAA regimens linked to reduced diabetes risk
Diabetes incidence was lower in hepatitis C patients treated with DAAs than in untreated patients.
Conference Coverage
It’s time for universal HCV screening in the ED
SAN FRANCISCO –
Conference Coverage
Hepatitis C debrief: Therapy has matured, access issues remain
Hepatitis C virus treatments are now broadly available, but challenges remain in getting the treatments to those who need them.
Conference Coverage
Early treatment with direct-acting antivirals linked to reduced medical costs in noncirrhotic HCV
Conference Coverage
Hep C–infected livers are safe for transplant
SAN FRANCISCO – An analysis shows no difference in graft survival or overall survival when a donated liver is...
Conference Coverage
High rates of HCV treatment completion seen in people who inject drugs
Treatment of people who inject drugs will help prevent new cases of HCV, study coauthor maintains.
Conference Coverage
High rates of prescription opioid, benzodiazepine use observed in chronic liver disease
SAN FRANCISCO – Nearly one-quarter were receiving substantial high-dose opioid prescriptions.
News
Good news, bad news about HCV in kidney disease
While new drugs wipe out the virus, outbreaks are still hitting dialysis clinics.
Conference Coverage
Opiate use tied to hepatitis C risk in youth
SAN FRANCISCO – A large, nationwide survey suggests the need for more hepatitis C virus testing among adolescents and young adults with opiate use...